Medical workers care and comfort a patient who is suffering from the Covid-19 virus at the UMASS Memorial DCU Center Field Hospital in Worcester, Massachusetts on January 13, 2021. - The field ...

New findings out from Yale University suggest autoantibodies — or proteins acting against a person’s own tissues and organs — may correlate with COVID-19 severity and lasting symptoms. In some ...

Please provide your email address to receive an email when new articles are posted on . “Disclaimer: this is a controversial topic,” Leonard Calabrese, DO, told attendees. Calabrese acknowledged a ...

A new study shows that about two percent of the population develop autoantibodies against type 1 interferons, mostly later in life. This makes individuals more susceptible to viral diseases like COVID ...

A new study shows that about two percent of the population develop autoantibodies against type 1 interferons, mostly later in life. This makes individuals more susceptible to viral diseases like COVID ...

This the third and final article in a three-part series on fading immunity to Covid-19 and the flu—the science behind it, and the implications it has for vaccine development and the pandemic at large.

Scientists find aberrant immune system in patients with virus could also be cause of ‘long Covid’ Dramatic levels of “friendly fire” from the immune system may drive severe Covid-19 disease and leave ...

Autoantibodies are typically associated with immunopathology, but a recent study in Cell has identified a tissue-protective role for such antibodies. Meyer et al. report that patients with autoimmune ...

The potential roles for autoantibodies in renal transplantation are increasing, as illustrated by a recent report of polyreactive autoantibodies produced by B-cell clones from a kidney transplant ...

Cancer still accounts for nearly 1 in every 4 deaths worldwide. New immunotherapies have the power to induce durable responses in patients with fatal cancers, but only a small percentage of patients ...

The study shows that only two per cent of the population develop autoantibodies, making them susceptible to viral diseases like COVID-19. A new study shows that about two per cent of the population ...